Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK.
Dixon G, Hague S, Mulholland S, Adamali H, Khin AMN, Thould H, Connon R, Minnis P, Murtagh E, Khan F, Toor S, Lawrence A, Naqvi M, West A, Coker RK, Ward K, Yazbeck L, Hart S, Garfoot T, Newman K, Rivera-Ortega P, Stranks L, Beirne P, Bradley J, Rowan C, Agnew S, Ahmad M, Spencer LG, Aigbirior J, Fahim A, Wilson AM, Butcher E, Chong SG, Saini G, Zulfikar S, Chua F, George PM, Kokosi M, Kouranos V, Molyneaux P, Renzoni E, Vitri B, Wells AU, Nicol LM, Bianchi S, Kular R, Liu H, John A, Barth S, Wickremasinghe M, Forrest IA, Grimes I, Simpson AJ, Fletcher SV, Jones MG, Kinsella E, Naftel J, Wood N, Chalmers J, Crawshaw A, Crowley LE, Dosanjh D, Huntley CC, Walters GI, Gatheral T, Plum C, Bikmalla S, Muthusami R, Stone H, Rodrigues JCL, Tsaneva-Atanasova K, Scotton CJ, Gibbons MA, Barratt SL. Dixon G, et al. Among authors: naqvi m. ERJ Open Res. 2024 Jan 15;10(1):00529-2023. doi: 10.1183/23120541.00529-2023. eCollection 2024 Jan. ERJ Open Res. 2024. PMID: 38226064 Free PMC article.
Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study.
Raman L, Stewart I, Barratt SL, Chua F, Chaudhuri N, Crawshaw A, Gibbons M, Hogben C, Hoyles R, Kouranos V, Martinovic J, Mulholland S, Myall KJ, Naqvi M, Renzoni EA, Saunders P, Steward M, Suresh D, Thillai M, Wells AU, West A, Mitchell JA, George PM. Raman L, et al. Among authors: naqvi m. ERJ Open Res. 2023 Mar 20;9(2):00423-2022. doi: 10.1183/23120541.00423-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 36949962 Free PMC article.
Patient perspectives on home-spirometry in interstitial lung disease: a qualitative co-designed study.
Mandizha J, Lanario JW, Duckworth A, Lines S, Paiva A, Elworthy V, Muraleedharan V, Da Ponte AJ, Shuttleworth R, Brown G, Almond H, Bond C, Cosby M, Dallas J, Naqvi M, Russell AD, Berry A, Gibbons M, Scotton CJ, Russell AM. Mandizha J, et al. Among authors: naqvi m. BMJ Open Respir Res. 2023 Oct;10(1):e001837. doi: 10.1136/bmjresp-2023-001837. BMJ Open Respir Res. 2023. PMID: 37793682 Free PMC article.
Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease.
Hannah JR, Lawrence A, Martinovic J, Naqvi M, Chua F, Kouranos V, Ali SS, Stock C, Owens C, Devaraj A, Pollard L, Agarwal S, Atienza-Mateo B, González-Gay MA, Patel A, West A, Tinsley K, Robbie H, Lams B, Wells AU, Norton S, Galloway J, Renzoni EA, Gordon PA. Hannah JR, et al. Among authors: naqvi m. Rheumatology (Oxford). 2024 Nov 1;63(11):3080-3090. doi: 10.1093/rheumatology/kead638. Rheumatology (Oxford). 2024. PMID: 38039151 Free PMC article.
The diagnosis and management of systemic autoimmune rheumatic disease-related interstitial lung disease: British Society for Rheumatology guideline scope.
Hannah J, Rodziewicz M, Mehta P, Heenan KM, Ball E, Barratt S, Carty S, Conway R, Cotton CV, Cox S, Crawshaw A, Dawson J, Desai S, Fahim A, Fielding C, Garton M, George P, Gunawardena H, Kelly C, Khan F, Koduri G, Morris H, Naqvi M, Perry E, Riddell C, Sieiro Santos C, Spencer LG, Chaudhuri N, Nisar MK. Hannah J, et al. Among authors: naqvi m. Rheumatol Adv Pract. 2024 Apr 18;8(2):rkae056. doi: 10.1093/rap/rkae056. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 38765189 Free PMC article. Review.
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.
Carpp LN, Hyrien O, Fong Y, Benkeser D, Roels S, Stieh DJ, Van Dromme I, Van Roey GA, Kenny A, Huang Y, Carone M, McDermott AB, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Lu Y, Yu C, Juraska M, Hejazi NS, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Bekker LG, Gaur AH, Veloso VG, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Vandebosch A, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Follmann D, Koup RA, Donis RO, Gilbert PB; Immune Assays Team; Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team; United States Government (USG)/CoVPN Biostatistics Team. Carpp LN, et al. Among authors: naqvi m. Nat Commun. 2024 Nov 12;15(1):9785. doi: 10.1038/s41467-024-53727-y. Nat Commun. 2024. PMID: 39532861 Free PMC article. Clinical Trial.
220 results